Results 121 to 130 of about 47,373 (236)
Progress in Neurology and Psychiatry, Volume 30, Issue 1, February 2026.ABSTRACT This case highlights a relapse of major depressive disorder in an elderly man following a flu‐like illness, with clinical features and laboratory findings supporting a possible inflammatory contribution. It emphasises the relevance of the inflammatory theory of depression, especially in individuals with late‐life depression and recent immune ...
Nauman Malik, Mohamed A. Mohamed
wiley +1 more source
The Effect of Small Molecules on Sterol Homeostasis: Measuring 7-Dehydrocholesterol in Dhcr7-Deficient Neuro2a Cells and Human Fibroblasts [PDF]
, 2018 K
Balogh, István +8 more
core +1 more source
Duplicate Prescription Patterns in Patients With Substance Use Disorders
Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.ABSTRACT This study sought to investigate the frequency and characteristics of duplicate prescriptions (DPs) in psychiatric inpatients with substance use disorders using a DP classification that differentiates between appropriate DPs (ADPs) and potentially inappropriate DPs (PIDPs). The study was conducted as a monocentric retrospective cross‐sectional
Johannes Heck +8 more
wiley +1 more source
Journal of Sleep Research, Volume 35, Issue 1, February 2026.ABSTRACT This study aimed to investigate the efficacy of a Danish adaption of a transdiagnostic sleep and circadian intervention, combining cognitive behavioural therapy for insomnia with chronotherapy. A randomised controlled trial enrolling 88 outpatients with depression, attention deficit disorder, or bipolar disorder suffering from insomnia or ...
Mette Kragh +5 more
wiley +1 more source
Case Reports in Psychiatry, 2015 Introduction. Akathisia affects around 18% of patients with bipolar disorder treated with aripiprazole and may worsen when aripiprazole is combined with lamotrigine and antidepressants. Case.
Milena Pereira Pondé +1 more
doaj +1 more source
Journal of Pharmacological Sciences, 2014 .: Aripiprazole is used clinically as an atypical antipsychotic. We evaluated the effect of in vivo treatment with aripiprazole on the proliferation and differentiation of neural stem/progenitor cells in a mouse model, trimethyltin-induced neuronal loss ...
Masanori Yoneyama +7 more
doaj +1 more source
Therapeutic Advances in Psychopharmacology, 2019 Background: Aripiprazole lauroxil (AL), a long-acting injectable antipsychotic for the treatment of schizophrenia in adults, can be started with either 21 days of daily oral aripiprazole supplementation or a 1-day initiation regimen consisting of a ...
Marjie L. Hard +6 more
doaj +1 more source
Aripiprazole Induced Acute Transient Bilateral Myopia: A Case Report
Balkan Medical Journal, 2015 Background: Aripiprazole is an atypical antipsychotic drug. Acute transient myopia is a rare response to systemic medication. Unspecified ocular side effects of aripiprazole have rarely been reported.
Hasan Karadağ, Kadir Özdel, Mutlu Acar
doaj +1 more source
Worsened hypertension control induced by aripiprazole
Neuropsychiatric Disease and Treatment, 2013 Norio Yasui-Furukori, Akira Fujii Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan Abstract: Aripiprazole is widely used in the treatment of schizophrenia and bipolar disorders.
Yasui-Furukori N, Fujii A
doaj
An Exploratory Analysis of Pharmaceutical Price Disparities and Their Implications Among Six Developed Nations [PDF]
, 2006 In our study of 43 drugs, prescription drug prices in several wealthy nations (Australia, Canada, France, Germany, and the U.K.) were much lower than in the U.S. on average, well below relative per capita GDP. There was relatively little difference among
Elizabeth DuPre +2 more
core